MHRA-100599-PIP01-22

Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • Flortaucipir F18
Invented Name
  • Tauvid
  • Tauvid
PIP Number MHRA-100599-PIP01-22
Pharmaceutical form(s)
Pharmaceutical form(s):
  • All pharmaceutical forms
Therapeutic area
Therapeutic area:
  • Neurology
Conditions / Indications
Conditions / Indications:
  • Diagnosis of Alzheimer's disease
Route(s) of administration
Route(s) of administration:
  • intravenous
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Flortaucipir F18.pdf
Published Date 25/05/2023